BioCentury
ARTICLE | Company News

AVI BioPharma, Medtronic in coated stent deal

May 22, 2001 7:00 AM UTC

MDT received an exclusive worldwide license from AVII to a family of antisense compounds, including Resten-NG, for loading on medical devices such as stents. AVII will receive a $10 million equity inv...